See full profile.
Participants maintained a reduced dosing frequency for an average of 36 weeks
"starting at" prices mislead because dose-step structures raise the bill once you reach maintenance
Reported eligibility frameworks have referenced combinations such as: Overweight or obesity alongside prediabetes or cardiovascular disease Obesity combined with conditions like heart failure, hypertension, or chronic kidney disease Ultimately, however, final eligibility rules, prior authorization requirements, and clinical thresholds will be determined by participating Medicare Part D plans and CMS guidance closer to launch
Some patients experience severe symptoms at doses that others tolerate, which is why PlexusDx recommends starting low and titrating slowly under medical guidance rather than jumping to higher doses hoping for faster results
Standards of Medical Care in Diabetes2021. Diabetes Care, 44(Supplement 1), S1-S232